Rehard Robert 4
4 · REGAL REXNORD CORP · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Regal Rexnord (RRX) CFO Robert Rehard Sells Shares
What Happened
Robert Rehard, Executive Vice President and Chief Financial Officer of Regal Rexnord (RRX), sold a total of 2,257 shares in open-market transactions on February 24–25, 2026 for aggregate proceeds of approximately $503,479. The sales were: 1,289 shares on 2026-02-24 at an average price of $223.13 (proceeds ~$287,615) and 968 shares on 2026-02-25 at $223.00 (proceeds ~$215,864). These were sales (S) — routine dispositions rather than purchases.
Key Details
- Transaction dates and prices:
- 2026-02-24: 1,289 shares sold at weighted avg $223.13 (prices ranged $223.00–$223.24) — ~$287,615
- 2026-02-25: 968 shares sold at $223.00 — ~$215,864
- Total shares sold: 2,257; total proceeds: ~$503,479.
- The filing notes the price reported is a weighted average (Footnote F1); exact per-share prices ranged $223.00–$223.24 and can be provided on request.
- Shares owned after the transactions: not specified in the data you provided — see the Form 4 for post-transaction beneficial ownership.
- Vesting/award footnotes (F2, F3) describe stock appreciation right schedules included on the Form 4; they are vesting schedules, not the transactions reported here.
- Filing timeliness: Form filed 2026-02-26 for trades on 2026-02-24 and 02-25; this appears to have been filed within the standard two-business-day window (timely).
Context
These were open-market sales by the company’s CFO. Sales are routine insider activity and do not by themselves indicate company performance or management view. The filing includes vesting schedule notes for certain stock appreciation rights (F2, F3) unrelated to these specific sale transactions.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-02-24$223.13/sh−1,289$287,615→ 35,414.954 total - Sale
Common Stock
2026-02-25$223.00/sh−968$215,864→ 34,446.954 total
- 2,164
Stock Appreciation Rights
[F2]Exercise: $76.99From: 2019-05-10Exp: 2027-05-10→ Common Stock (2,164 underlying) - 7,730
Stock Appreciation Rights
[F2]Exercise: $74.04From: 2020-05-09Exp: 2028-05-09→ Common Stock (7,730 underlying) - 15,382
Stock Appreciation Rights
[F2]Exercise: $78.05From: 2021-05-08Exp: 2029-05-08→ Common Stock (15,382 underlying) - 12,340
Stock Appreciation Rights
[F3]Exercise: $84.39From: 2021-02-18Exp: 2030-02-18→ Common Stock (12,340 underlying) - 9,276
Stock Appreciation Rights
[F3]Exercise: $133.77From: 2022-02-23Exp: 2031-02-23→ Common Stock (9,276 underlying) - 8,292
Stock Appreciation Rights
[F3]Exercise: $151.27From: 2023-02-23Exp: 2032-02-23→ Common Stock (8,292 underlying) - 9,456
Stock Appreciation Rights
[F3]Exercise: $154.20From: 2024-02-23Exp: 2033-02-23→ Common Stock (9,456 underlying) - 7,657
Stock Appreciation Rights
[F3]Exercise: $168.47From: 2025-02-23Exp: 2034-02-23→ Common Stock (7,657 underlying)
Footnotes (3)
- [F1]The price in Column 4 is a weighted average price. The prices actually received ranged from $223.00 to $223.24. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
- [F2]The Stock Appreciation Rights vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant.
- [F3]The Stock Appreciation Rights vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.